Skip to main content

Advertisement

Log in

Hodgkin's and Castleman's disease in a patient with systemic mastocytosis

  • CASE REPORT
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

 Systemic mastocytosis is a rare condition characterized clinically by the local consequences of vasoactive peptides released from infiltrating mast cells in the reticuloendothelial tissues. Mast cells originate from the pluripotent bone marrow stem cells; it is therefore not surprising that myeloproliferative and myelodysplastic disorders commonly coexist or terminate the clinical phase of mastocytosis. We report here, to our knowledge, the first case of Hodgkin's and Castleman's disease occurring in a patient with co-existent systemic mastocytosis, which remained unchanged after combination chemotherapy for Hodgkin's disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received: December 18, 1997 / Accepted: September 8, 1998

Rights and permissions

Reprints and permissions

About this article

Cite this article

Saletti, P., Ghielmini, M., Scali, G. et al. Hodgkin's and Castleman's disease in a patient with systemic mastocytosis. Ann Hematol 78, 97–100 (1999). https://doi.org/10.1007/s002770050482

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s002770050482

Navigation